Massachusetts Financial Services Co. MA grew its holdings in Humana Inc. (NYSE:HUM – Free Report) by 273.2% during the third quarter, Holdings Channel reports. The firm owned 3,488,261 shares of the insurance provider’s stock after acquiring an additional 2,553,509 shares during the quarter. Massachusetts Financial Services Co. MA’s holdings in Humana were worth $907,541,000 at the end of the most recent quarter.
Several other large investors have also added to or reduced their stakes in the business. Donoghue Forlines LLC acquired a new position in Humana in the third quarter valued at approximately $2,065,000. Sequoia Financial Advisors LLC increased its stake in shares of Humana by 34.8% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 5,109 shares of the insurance provider’s stock valued at $1,329,000 after acquiring an additional 1,319 shares in the last quarter. Evergreen Capital Management LLC acquired a new position in shares of Humana during the 3rd quarter valued at $244,000. First National Advisers LLC grew its holdings in Humana by 3.8% in the third quarter. First National Advisers LLC now owns 2,809 shares of the insurance provider’s stock worth $731,000 after purchasing an additional 104 shares during the period. Finally, Belfer Management LLC acquired a new position in shares of Humana during the third quarter valued at about $202,000. Institutional investors and hedge funds own 92.38% of the company’s stock.
Wall Street Analysts Forecast Growth
Several analysts have recently commented on the company. Mizuho raised their target price on Humana from $300.00 to $345.00 and gave the company an “outperform” rating in a research note on Thursday, October 9th. Morgan Stanley restated an “underperform” rating on shares of Humana in a report on Thursday, December 18th. Jefferies Financial Group raised Humana from a “hold” rating to a “buy” rating and upped their target price for the stock from $253.00 to $313.00 in a research report on Friday, December 5th. Truist Financial reduced their price target on shares of Humana from $300.00 to $285.00 and set a “hold” rating for the company in a research report on Monday, November 10th. Finally, The Goldman Sachs Group decreased their price target on shares of Humana from $235.00 to $215.00 and set a “sell” rating for the company in a research note on Monday, November 24th. Eight equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and five have assigned a Sell rating to the company’s stock. According to MarketBeat, Humana currently has an average rating of “Hold” and a consensus target price of $293.37.
Humana Stock Performance
Shares of HUM stock opened at $273.02 on Friday. Humana Inc. has a one year low of $206.87 and a one year high of $315.35. The company has a market cap of $32.84 billion, a P/E ratio of 25.59, a P/E/G ratio of 2.25 and a beta of 0.45. The firm has a 50-day moving average of $255.33 and a 200-day moving average of $263.63. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.02 and a quick ratio of 2.02.
Humana (NYSE:HUM – Get Free Report) last posted its quarterly earnings data on Wednesday, November 5th. The insurance provider reported $3.24 EPS for the quarter, beating the consensus estimate of $2.95 by $0.29. Humana had a net margin of 1.02% and a return on equity of 12.86%. The firm had revenue of $32.65 billion during the quarter, compared to analyst estimates of $31.99 billion. During the same quarter last year, the business posted $4.16 EPS. The company’s revenue for the quarter was up 11.1% on a year-over-year basis. Equities research analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.
Humana Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Friday, December 26th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date is Friday, December 26th. Humana’s dividend payout ratio (DPR) is 33.18%.
Humana Company Profile
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Read More
- Five stocks we like better than Humana
- Wall Street Alert: Buy AES
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- URGENT: Trump Just Triggered AI’s Biggest Disruption Yet
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
